期刊文献+

VEGF与卵巢癌的研究进展 被引量:3

Research progress on VEGF and ovarian cancer
下载PDF
导出
摘要 血管内皮生长因子(VEGF)及其受体在卵巢癌高表达,与卵巢癌的发生、发展、转移和预后等密切相关。VEGF受体不仅有酪氨酸激酶活性,而且可刺激血管内皮的分裂、增殖,促进肿瘤血管的生成,提高微血管的通透性,加快肿瘤细胞与血管内营养物质的交换,促进肿瘤的发生、发展。 Vascular endothelial growth factor (VEGF)is a highly specific mitogen for vascular endothelial cells.It po-tentiates angiogenesis and promotes the vascular permeability.Strong expression of VEGF and its receptor has been found in various solid tumor types,including ovarian carcinoma.VEGF receptor not only has tyrosine kinase activity,but also can stimulate endothelial division,proliferation,promote angiogenesis,improve microvascular permeability,accelerate the exchange of nutrients tumor cells and blood vessels,promoting the development of tumor.
出处 《中国当代医药》 2014年第22期186-188,共3页 China Modern Medicine
基金 河南省漯河市科技进步一等奖(2011233)
关键词 血管内皮生长因子 血管生成抑制剂 卵巢癌 Vascular endothelial growth factor Angiogenes inhibitor Ovarian cancer
  • 相关文献

参考文献26

  • 1Martin L,Schilder R.Novel approaches in advancing the treatment ofepithelial ovarian cancer:the role of angiogenesis inhibition[J].J Clin Oncol, 2007,25 (20) : 2894-2901.
  • 2Olsson AK,Dimberg A,Kreuger J,et a/.VEGF receptor signalling-in control of vascular function[J].Nat Rev Mol Cell Bial,2010,7(5):359- 371.
  • 3陶厚权,王瑞年,林言箴.血管内皮生长因子与肿瘤[J].肿瘤,1997,17(1):52-54. 被引量:13
  • 4Stylianidou A,Van'as M ,Akrivis C ,et a/.Sclerosing stromal tumor of the ovary:a case report and review of the literature[J].Eur J Gynaecol Oncol, 2001,22(4) :300-304.
  • 5李丽珍,闫树昕.检测卵巢肿瘤病人血清中血管内皮生长因子浓度的临床意义[J].医学检验与临床,2004,16(3):8-9. 被引量:3
  • 6Nakanishi Y, Kodama J,Yoshinouchi M,et al.The expression of vascular endothelial growth factor and transforming growth factor beta associates with angiogenesis in epithelial ovarian cancer[J].Int J Gynecol Pathol, 1997,16(3) :256-262.
  • 7Kiselyov A,Balakin KV,Tkachenko SE.VEGF/VEGFR signalling as a target for inhibiting angiogenesis[J].Expert Opin Investig Drugs,2007, 16( 1 ) : 83-107.
  • 8陈川(综述),俞德超(审阅),滕理送(审阅).以VEGF/VEGFR为靶点的抗肿瘤药物的研究进展[J].中国肿瘤生物治疗杂志,2007,14(3):291-295. 被引量:25
  • 9Jain RK.Normalization of tumor vasculature:an emerging concept in autiangiogenic therapy [J].Science ,2005,307 (5706) : 58-62.
  • 10Lohela M ,Bry M ,Tammela T,et a/.VEGFs and receptors involved in angiogenesis versus lymphangiogenesis[J].Curr Opin Cell Biol,2009, 21 (2) : 154-165.

二级参考文献44

  • 1寿成超.抗血管生成与肿瘤生物治疗[J].中国肿瘤生物治疗杂志,2006,13(6):401-403. 被引量:3
  • 2Roy H,Bhardwaj S,Yla-Herttuala S.Biology of vascular endothelial growth factors[J].FEBS Letters,2006,580(12):2879-2887.
  • 3Xie K,Wei D,Shi Q,et al.Constitutive and inducible expression and regulation of vascular endothelial growth factor[J].Cytokine Growth Factor Rev,2004,15(5):297-324.
  • 4Zachary I,Gliki G.Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family[J].Cardiovasc Res,2001,49(3):568-581.
  • 5Ferrara N,Gerber HP,LeCouter J.The biology of VEGF and its receptors[J].Nat Med,2003,9(6):669-676.
  • 6Saharinen P,Tammela T,Karkkainen MJ,et al.Lymphatic vasculature:development,molecular regulation and role in tumor metastasis and inflammation[J].Trends Immunol,2004,25(7):387-395.
  • 7Ferrara N,Hillan KJ,Gerber HP,et al.Discovery and development of bevacizumab,an anti-VEGF antibody for treating cancer[J].Nat Rev Drug Discov,2004,3(5):391-400.
  • 8Gerber HP,Ferrara N.Pharmacology of bevacizumab as monotherapy or in combination with cytotoxic therapy in preclinical studies[J].Cancer Res,2005,65(3):671-680.
  • 9Kim KJ,Li B,Winer J,et al.Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo[J].Nature,1993,362(6423):841-844.
  • 10Hurwitz H,Fehrenbacher L,Novotny W,et al.Bevacizumab plus irinotecan,fluorouracil,and leucovorin for metastatic colorectal cancer[J].N Engl J Med,2004,350(23):2335-2342.

共引文献41

同被引文献22

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部